United Therapeutics CorpNASDAQ:UTHR
- LAST PRICE400.8700
- TODAY'S CHANGE (%)0.4300 (0.1074%)
- Bid / Lots395.0000/ 1
- Ask / Lots400.6500/ 1
- Open / Previous Close401.8900 / 400.4400
- Day Range
- 52 Week Range
- Volume356,947
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | UTHR |
|---|---|---|
| 09:32 ET | 6113 | 399.225 |
| 09:33 ET | 300 | 398.73 |
| 09:35 ET | 600 | 403 |
| 09:37 ET | 300 | 402.455 |
| 09:39 ET | 505 | 403.835 |
| 09:42 ET | 703 | 402.57 |
| 09:44 ET | 100 | 402.57 |
| 09:46 ET | 1300 | 404.23 |
| 09:48 ET | 340 | 404.12 |
| 09:50 ET | 100 | 406.21 |
| 09:51 ET | 310 | 404.09 |
| 09:53 ET | 500 | 404.83 |
| 09:55 ET | 800 | 404.95 |
| 09:57 ET | 400 | 403.7774 |
| 10:00 ET | 500 | 404.435 |
| 10:02 ET | 400 | 404.45 |
| 10:04 ET | 1000 | 406.4 |
| 10:06 ET | 400 | 405.84 |
| 10:08 ET | 600 | 405.185 |
| 10:09 ET | 1864 | 405.145 |
| 10:11 ET | 1400 | 403.845 |
| 10:13 ET | 400 | 404.68 |
| 10:15 ET | 100 | 405.11 |
| 10:18 ET | 200 | 405.935 |
| 10:20 ET | 100 | 405.94 |
| 10:27 ET | 520 | 405.19 |
| 10:29 ET | 300 | 405.155 |
| 10:31 ET | 3863 | 404.775 |
| 10:33 ET | 100 | 404.775 |
| 10:36 ET | 1000 | 404.625 |
| 10:42 ET | 2100 | 404.015 |
| 10:44 ET | 701 | 403.705 |
| 10:49 ET | 200 | 402.97 |
| 10:51 ET | 300 | 403.64 |
| 10:56 ET | 200 | 402.97 |
| 11:00 ET | 500 | 402.26 |
| 11:02 ET | 200 | 401.27 |
| 11:05 ET | 300 | 401.245 |
| 11:12 ET | 2807 | 401.25 |
| 11:14 ET | 1315 | 401.04 |
| 11:16 ET | 8755 | 401.64 |
| 11:18 ET | 638 | 402.545 |
| 11:20 ET | 1780 | 403.71 |
| 11:21 ET | 357 | 403.065 |
| 11:25 ET | 200 | 403.065 |
| 11:27 ET | 225 | 403.13 |
| 11:32 ET | 700 | 403.49 |
| 11:34 ET | 1125 | 404.675 |
| 11:36 ET | 1800 | 405.045 |
| 11:39 ET | 6600 | 404.335 |
| 11:41 ET | 8700 | 404.53 |
| 11:43 ET | 300 | 405.16 |
| 11:48 ET | 200 | 404.4 |
| 11:50 ET | 5100 | 404.33 |
| 11:52 ET | 300 | 404.6 |
| 11:54 ET | 1500 | 405.58 |
| 11:56 ET | 400 | 406.42 |
| 11:57 ET | 600 | 406.08 |
| 11:59 ET | 200 | 405.875 |
| 12:01 ET | 632 | 404.72 |
| 12:03 ET | 1250 | 403.55 |
| 12:12 ET | 300 | 402.25 |
| 12:14 ET | 1953 | 401.8 |
| 12:15 ET | 100 | 402.355 |
| 12:17 ET | 400 | 402.3762 |
| 12:26 ET | 493 | 401.65 |
| 12:28 ET | 4700 | 401.77 |
| 12:30 ET | 862 | 401.84 |
| 12:32 ET | 845 | 402.02 |
| 12:33 ET | 900 | 402.09 |
| 12:37 ET | 1000 | 402.72 |
| 12:42 ET | 624 | 402.7224 |
| 12:44 ET | 600 | 403.04 |
| 12:46 ET | 200 | 402.47 |
| 12:50 ET | 700 | 402.445 |
| 12:51 ET | 900 | 403.02 |
| 12:53 ET | 900 | 403.1 |
| 12:55 ET | 2480 | 401.98 |
| 12:57 ET | 100 | 402.19 |
| 01:02 ET | 180 | 401.36 |
| 01:08 ET | 900 | 402.575 |
| 01:18 ET | 600 | 402.39 |
| 01:20 ET | 208 | 402.39 |
| 01:24 ET | 100 | 402.615 |
| 01:26 ET | 168 | 403.2099 |
| 01:27 ET | 100 | 402.66 |
| 01:29 ET | 200 | 402.68 |
| 01:33 ET | 300 | 402.69 |
| 01:36 ET | 100 | 402.69 |
| 01:44 ET | 100 | 403.035 |
| 01:47 ET | 200 | 403.035 |
| 01:51 ET | 100 | 403.2 |
| 01:54 ET | 200 | 403.1113 |
| 01:58 ET | 250 | 403.75 |
| 02:00 ET | 853 | 404.58 |
| 02:02 ET | 100 | 404.585 |
| 02:05 ET | 510 | 404.6 |
| 02:07 ET | 1891 | 404.165 |
| 02:09 ET | 100 | 404.165 |
| 02:12 ET | 362 | 404.165 |
| 02:14 ET | 100 | 404.175 |
| 02:16 ET | 1561 | 403.5 |
| 02:18 ET | 200 | 402.68 |
| 02:21 ET | 2801 | 403.46 |
| 02:23 ET | 200 | 403.56 |
| 02:25 ET | 1300 | 403.53 |
| 02:27 ET | 500 | 403.67 |
| 02:30 ET | 3711 | 403.6 |
| 02:32 ET | 2829 | 404.07 |
| 02:34 ET | 900 | 403.21 |
| 02:36 ET | 300 | 403.19 |
| 02:41 ET | 217 | 403.165 |
| 02:43 ET | 135 | 403.165 |
| 02:48 ET | 1500 | 402.37 |
| 02:50 ET | 2039 | 403.23 |
| 02:52 ET | 1100 | 402.76 |
| 02:54 ET | 685 | 402.42 |
| 02:56 ET | 700 | 402.45 |
| 02:59 ET | 100 | 402.355 |
| 03:01 ET | 100 | 402.355 |
| 03:03 ET | 2394 | 402.325 |
| 03:08 ET | 100 | 402.315 |
| 03:10 ET | 800 | 401.89 |
| 03:12 ET | 300 | 401.91 |
| 03:14 ET | 200 | 401.9 |
| 03:15 ET | 2501 | 401.965 |
| 03:17 ET | 200 | 402.06 |
| 03:19 ET | 100 | 402.08 |
| 03:21 ET | 100 | 402.065 |
| 03:24 ET | 200 | 402.05 |
| 03:26 ET | 100 | 402.33 |
| 03:28 ET | 300 | 402.01 |
| 03:30 ET | 1325 | 401.81 |
| 03:32 ET | 2193 | 401.625 |
| 03:33 ET | 1700 | 401.8 |
| 03:35 ET | 100 | 401.88 |
| 03:37 ET | 1300 | 401.5975 |
| 03:39 ET | 700 | 401.715 |
| 03:42 ET | 200 | 401.5625 |
| 03:44 ET | 300 | 401.4 |
| 03:46 ET | 600 | 401.43 |
| 03:48 ET | 1015 | 400.5131 |
| 03:50 ET | 1200 | 400.915 |
| 03:51 ET | 1700 | 401.14 |
| 03:53 ET | 1022 | 400.61 |
| 03:55 ET | 7477 | 401.1 |
| 03:57 ET | 2662 | 400.21 |
| 04:00 ET | 65999 | 400.87 |
Nov 5, 2024
United Therapeutics Corporation to Present at the UBS Global Healthcare Conference, from 4:30PM ET on Tuesday Nov 05, 2024 by Dow Jones
4:30PM ET on Tuesday Nov 05, 2024 by Dow Jones
Nov 1, 2024
DJ United Therapeutics Is Maintained at Neutral by Goldman Sachs, from 1:32PM ET on Friday Nov 01, 2024 by Dow Jones
1:32PM ET on Friday Nov 01, 2024 by Dow Jones
Oct 31, 2024
DJ United Therapeutics Is Maintained at Buy by Ladenburg Thalmann, from 3:07PM ET on Thursday Oct 31, 2024 by Dow Jones
3:07PM ET on Thursday Oct 31, 2024 by Dow JonesDJ United Therapeutics Is Maintained at Outperform by Oppenheimer, from 2:18PM ET on Thursday Oct 31, 2024 by Dow Jones
2:18PM ET on Thursday Oct 31, 2024 by Dow JonesDJ United Therapeutics Is Maintained at Buy by Argus Research, from 10:23AM ET on Thursday Oct 31, 2024 by Dow Jones
10:23AM ET on Thursday Oct 31, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
United Therapeutics Corp | 17.9B | 17.6x | +8.22% |
BioMarin Pharmaceutical Inc | 12.6B | 39.8x | --- |
Beigene Ltd | 23.4B | -38.1x | --- |
Neurocrine Biosciences Inc | 12.9B | 34.0x | +62.04% |
Medpace Holdings Inc | 11.3B | 31.6x | +35.10% |
Exact Sciences Corp | 9.5B | -42.8x | --- |
Company Information
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Contact Information
- Headquarters
- 1000 SPRING STSILVER SPRING, MD, United States 20910
- Phone
- 301-608-9292
- Fax
- 301-608-9291
Executives
- Chairman of the Board, Chief Executive Officer
- Martine Rothblatt
- President, Chief Operating Officer
- Michael Benkowitz
- Lead Independent Vice Chairman of the Board
- Christopher Patusky
- Chief Financial Officer, Treasurer
- James Edgemond
- Executive Vice President, General Counsel, Corporate Secretary
- Paul Mahon
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $17.9B |
|---|---|
Revenue (TTM) | $2.8B |
Shares Outstanding | 44.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.57 |
EPS | $22.75 |
Book Value | $127.23 |
P/E Ratio | 17.6x |
Price/Sales (TTM) | 6.5 |
Price/Cash Flow (TTM) | 15.2x |
Operating Margin | 46.42% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
